Spots Global Cancer Trial Database for Investigation of the Cylex® ImmuKnow® Assay
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Investigation of the Cylex® ImmuKnow® Assay
Official Title: Investigation of the Cylex® ImmuKnow® Assay
Study ID: NCT00569842
Interventions
Study Description
Brief Summary: Currently, there is no accurate way of predicting the occurrence of Graft vs Host Disease (GvHD) or infection. The purpose of this study is to analyze blood with the ImmuKnow® Assay to see if doctors can detect which patients are at risk for GvHD and for getting an infection before they occur.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Indiana Universtiy Simon Cancer Center, Indianapolis, Indiana, United States
Contact Details
Name: Sherif Farag, MD, PhD
Affiliation: Indiana University School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
